The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis

Figure 7

Forest plot of the cancer-specific survival (CSS) of metformin use in patients with three main types of urinary system cancer: kidney cancer (a); bladder cancer (b); prostate cancer (c).

(a)

(b)

(c)